会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Selective cyclooxygenase-2 inhibitor patch
    • 选择性环加氧酶-2抑制剂贴片
    • US20050020658A1
    • 2005-01-27
    • US10683623
    • 2003-10-10
    • Katsuyuki InooKen-Ichi HattoriNoriko Shimizu
    • Katsuyuki InooKen-Ichi HattoriNoriko Shimizu
    • A61K9/70A61K31/415A61K31/42A61K31/18
    • A61K9/7053A61K9/7061A61K9/7076A61K31/415A61K31/42
    • A pharmaceutical composition for application to an area of skin of a subject for local and/or systemic treatment of a COX-2 mediated disorder comprises a backing sheet that is flexibly conformable to the area of skin, the backing sheet having opposing surfaces that are respectively distal and proximal to the skin when applied; and a coating on the proximal surface of the backing sheet that comprises (a) an adhesive, (b) an active agent comprising a selective COX-2 inhibitory sulfonamide drug of low water solubility, and (c) a solvent system for the active agent, wherein the active agent is in a therapeutically effective total amount and the solvent system is selected with regard to composition and amount thereof to be effective to maintain the active agent substantially completely in solubilized form. A method of local treatment of a site of pain and/or inflammation in a subject comprises applying the composition to a skin surface of the subject, preferably at a locus overlying or adjacent to the site of pain and/or inflammation, and leaving the composition in place for a time period effective to permit delivery of a locally therapeutic amount of the active agent. A method of systemic treatment of a subject having a COX-2 mediated disorder comprises applying the composition to a skin surface of the subject, and leaving the composition in place for a time period effective to permit transdermal delivery of a therapeutic amount of the active agent.
    • 用于局部和/或全身治疗COX-2介导的病症的受试者皮肤区域的药物组合物包括柔性地适应皮肤区域的背衬片,背衬片分别具有相对的表面 应用时远端和皮肤近端; 和背衬片的近侧表面上的涂层,其包含(a)粘合剂,(b)包含低水溶性的选择性COX-2抑制性磺酰胺药物的活性剂,和(c)活性剂的溶剂体系 其中活性剂处于治疗有效的总量,并且关于其组成和量的选择溶剂体系以有效地维持活性剂基本上完全为溶解形式。 局部治疗受试者的疼痛和/或炎症部位的方法包括将组合物施用于受试者的皮肤表面,优选在位于疼痛和/或炎症部位的上方或邻近的部位,并使组合物 在一段时间内有效地允许递送局部治疗量的活性剂。 具有COX-2介导的病症的受试者的全身治疗的方法包括将组合物施用于受试者的皮肤表面,并将组合物置于适当的时间段,以有效地允许经皮递送治疗量的活性剂 。